Is clopidogrel the antiplatelet drug of choice for high-risk patients with stroke/TIA?: No

被引：1
|
作者：
Hankey, GJ
机构：
[1] Royal Perth Hosp, Stroke Unit, Perth, WA 6001, Australia
[2] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 06期
关键词：
D O I：
10.1111/j.1538-7836.2005.01439.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1137 / 1140
页数：4
相关论文
共 50 条
  • [1] Is clopidogrel the antiplatelet drug of choice for high-risk patients with stroke/TIA?: Yes
    Diener, HC
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (06) : 1133 - 1136
  • [2] Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
    Johnston, S. Claiborne
    Easton, J. Donald
    Farrant, Mary
    Barsan, William
    Conwit, Robin A.
    Elm, Jordan J.
    Kim, Anthony S.
    Lindblad, Anne S.
    Palesch, Yuko Y.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (03): : 215 - 225
  • [3] Dual antiplatelet therapy in high risk patients with TIA or minor stroke
    Rodriguez Jorge, F.
    Garcia-Madrona, S.
    De Felipe Mimbrera, A.
    Cruz Culebras, A.
    Beltran Corbellini, A.
    Chico Garcia, J. L.
    Parra Diaz, P.
    Gomez Lopez, A.
    Sanchez Sanchez, A.
    Baena Alvarez, B.
    Matute Lozano, C.
    Vera Lechuga, R.
    Masjuan Vallejo, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 590 - 590
  • [4] Dual Antiplatelet Therapy for High-Risk TIA and Minor Stroke: BMJ Rapid Recommendation
    Croke, Lisa
    [J]. AMERICAN FAMILY PHYSICIAN, 2019, 100 (06) : 378 - 379
  • [5] Risk factors and antiplatelet therapy in TIA and stroke patients
    Puranen, J
    Laakso, M
    Riekkinen, P
    Sivenius, J
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 154 (02) : 200 - 204
  • [6] Treating High-Risk TIA and Minor Stroke Patients With Dual Antiplatelet Therapy: A National Survey of Emergency Medicine Physicians
    Liberman, Ava L.
    Lendaris, Andrea R.
    Cheng, Natalie T.
    Kaban, Nicole L.
    Rostanski, Sara K.
    Esenwa, Charles
    Kummer, Benjamin R.
    Labovitz, Daniel L.
    Prabhakaran, Shyam
    Friedman, Benjamin W.
    [J]. NEUROHOSPITALIST, 2022, 12 (01): : 13 - 18
  • [7] Under Treatment of High-Risk TIA Patients with Clopidogrel-Aspirin in the Emergency Setting
    Lendaris, Andrea R.
    Lessen, Samantha
    Cheng, Natalie T.
    Friedman, Benjamin W.
    Esenwa, Charles
    Labovitz, Daniel L.
    Prabhakaran, Shyam
    Lipton, Richard B.
    Liberman, Ava L.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (12):
  • [8] Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial
    Wangqin, Runqi
    Wang, Xianwei
    Wang, Yilong
    Xian, Ying
    Zhao, Xingquan
    Liu, Liping
    Li, Hao
    Meng, Xia
    Wang, Yongjun
    [J]. STROKE AND VASCULAR NEUROLOGY, 2017, 2 (04) : 176 - 183
  • [9] THE SIGNIFICANCE OF RISK-FACTORS IN THE EFFICACY OF ANTIPLATELET TREATMENT IN TIA AND STROKE PATIENTS
    SIVENIUS, J
    PURANEN, J
    LAAKSO, M
    RIEKKINEN, P
    [J]. NEUROLOGY, 1995, 45 (04) : A459 - A460
  • [10] Guideline: Starting dual antiplatelet therapy ≤ 24 h after high-risk TIA or minor ischemic stroke is recommended
    Uchino, Ken
    [J]. ANNALS OF INTERNAL MEDICINE, 2019, 170 (08) : JC38 - JC38
12345